Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma
Open Access
- 11 February 2002
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 86 (3) , 342-345
- https://doi.org/10.1038/sj.bjc.6600118
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group BLung Cancer, 2001
- Phase II Study of Vinorelbine in Patients With Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- A phase II study of gemcitabine in patients with malignant pleural mesotheliomaCancer, 1999
- A Proposed New International TNM Staging System for Malignant Pleural MesotheliomaChest, 1995
- The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trialsEuropean Journal Of Cancer, 1994
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- A phase II evaluation of cisplatin in unresectable diffuse malignant mesothelioma: A Southwest Oncology Group StudyInvestigational New Drugs, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958